Crystal structure of human kynurenine aminotransferase ii, a drug target for the treatment of schizophrenia*

HIGHLIGHTS

• who: Franca Rossi from the cognitive impairment (13-16) without exposing the brain to an abrupt and total loss of KAT activity and to the consequent deleterious effects on CNS function by the resulting KYNA deprivationAcknowledgments-We thank Prof. Robert Schwarcz from the Maryland Psychiatric Research Center (University of Maryland) for critical reading of the manuscript and helpful discussion. We thank the European Synchrotron Radiation Facility (ESRF, Grenoble, France) for data collections at the beam lines ID23, and BM14. have published the research: Crystal Structure of Human Kynurenine Aminotransferase II, a Drug Target for the Treatment of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.